Drug intelligence / Profile preview

Yi Shanfu

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

Yi Shanfu is a pharmaceutical drug, a brand name for Polyene Phosphatidylcholine Capsules. It is primarily used for the auxiliary improvement of various liver conditions, including toxic liver damage (e.g., liver damage caused by drugs, toxins, chemicals, and alcohol), fatty liver, and hepatitis. It also addresses associated symptoms such as loss of appetite and right upper abdominal pressure. The drug functions by delivering high-dose, readily absorbed polyene phosphatidylcholine, which is structurally similar to essential endogenous phospholipids. These molecules integrate into liver cell and organelle membranes, thereby aiding in the normalization of impaired liver function and enzyme activity, regulating the liver's energy balance, fostering liver tissue regeneration, facilitating the conversion of neutral fats and cholesterol into more metabolizable forms, and stabilizing bile. Additionally, it contributes to accelerating membrane regeneration and stabilization, inhibiting lipid peroxidation, and suppressing collagen synthesis. The drug is manufactured by Sanofi (Beijing) Pharmaceutical Co., Ltd.

Brand names
Yi ShanfuEssentiale NEssentiale Forte N
Other names
多烯磷脂酰胆碱胶囊Polyene Phosphatidylcholine Capsules
02

Targets

Hepatocyte and organelle phospholipid membranes

Beyond the preview

Go deeper on Yi Shanfu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi Shanfu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call